Hoth Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Hoth Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Hoth Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -89.7 %, a 12.7% increase year-over-year.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2023 was -76.3 %, a 44.9% increase from 2022.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2022 was -139 %, a 44.6% decline from 2021.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2021 was -95.8 %, a 27.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -76.3 +62.2 +44.9% Jan 1, 2023 Dec 31, 2023
2022 -139 -42.7 -44.6% Jan 1, 2022 Dec 31, 2022
2021 -95.8 +37 +27.8% Jan 1, 2021 Dec 31, 2021
2020 -133 +56.7 +29.9% Jan 1, 2020 Dec 31, 2020
2019 -190 +44.9 +19.1% Jan 1, 2019 Dec 31, 2019
2018 -234 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.